Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
Details for Australian Patent Application No. 2004291162 (hide)
International Classifications
Event Publications
15 June 2006 PCT application entered the National Phase
PCT publication WO2005/048952 Priority application(s): WO2005/048952
29 June 2006 Amendment Made
The nature of the amendment is: Amend the name of the co-inventor from Yuanpeng, Zhang to Zhang, Yuanpeng
1 May 2008 Assignment before Grant
Alza Corporation The application has been assigned to Intarcia Therapeutics, Inc.
30 July 2009 Application Accepted
Published as AU-B-2004291162
26 November 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004291163-Emulsifiable concentrates containing adjuvants
2004291152-Rescue agents for treating botulinum toxin intoxications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser